Molina Healthcare, Inc. (MOH) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. Molina Healthcare, Inc. provides managed healthcare services primarily through Medicaid, Medicare, and Marketplace programs. As of June 30, 2026, the company served approximately 4.9 million members across 21 states. The company operates four reportable segments: Medicaid, Medicare, Marketplace, and Other.
Key Financial Metrics
| Metric (in millions) | Q2 2026 | Q2 2025 | YTD 2026 | YTD 2025 |
|---|---|---|---|---|
| Total Revenue | $10,874 | $11,427 | $21,670 | $22,574 |
| Premium Revenue | $10,244 | $10,868 | $20,416 | $21,496 |
| Net Income | $60 | $255 | $74 | $553 |
| Diluted EPS | $1.19 | $4.75 | $1.46 | $10.19 |
| Operating Income | $145 | $373 | $228 | $806 |
| Medical Care Ratio (MCR) | 92.2% | 90.4% | 91.6% | 89.8% |
| Cash & Cash Equivalents | $4,985 | $4,499 | $4,985 | $4,499 |
| Long-Term Debt | $3,769 | $3,766 | $3,769 | $3,766 |
Liquidity: Net cash provided by operating activities for the six months ended June 30, 2026, was $788 million, a significant improvement from a use of $112 million in the prior year period. The company maintains a $1.25 billion revolving credit facility with no outstanding borrowings as of June 30, 2026.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 5% year-over-year for the six months ended June 30, 2026, driven primarily by a 14% decrease in membership (from 5.7 million to 4.9 million). This was due to general Medicaid market contraction, the expiration of the Virginia Medicaid contract, and a strategic reduction in Marketplace membership.
- Profitability Compression: Net income dropped significantly, with Q2 2026 net income at $60 million compared to $255 million in Q2 2025. Operating income fell from $373 million to $145 million in the quarter.
- Medical Cost Ratio: The consolidated Medical Care Ratio (MCR) increased to 92.2% in Q2 2026 from 90.4% in Q2 2025, reflecting a challenging medical cost environment across all segments.
- Impairment Charge: The company recorded a $93 million impairment charge in the first quarter of 2026 related to intangible assets (contract rights, provider networks, trade name) associated with the decision to exit the Medicare Advantage-Part D (MAPD) product in 2027 to focus on dual-eligible members.
- Segment Performance:
- Medicaid: Revenue remained relatively flat quarter-over-quarter but margins compressed due to higher MCR (92.7%).
- Marketplace: Revenue decreased 48% quarter-over-quarter due to strategic membership reductions; MCR increased to 88.9%.
- Medicare: Revenue decreased slightly; MCR increased to 90.7%.
Guidance, Outlook, and Risks
- Strategic Shift: Management is exiting the MAPD product in 2027 to focus exclusively on dual-eligible members in Medicare. They expect Medicare enrollment to decrease by approximately 12% in 2026.
- Membership Outlook: Total membership is expected to decrease to 4.5 million by year-end 2026. Marketplace enrollment is projected to drop to 250,000 members by year-end, with further reductions planned for 2027 to restore target margins.
- Legislative Risks: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 introduces work requirements and cost-sharing for Medicaid Expansion, expected to reduce enrollment by 2-3% annually through 2029. It also limits provider tax revenues and Marketplace subsidies.
- Legal Proceedings: The company is facing a securities class action lawsuit (Hindlemann v. Molina Healthcare, Inc.) regarding disclosures and earnings guidance, with a motion to dismiss hearing scheduled for September 2026. A shareholder derivative suit is currently stayed.
- Credit Rating: Standard & Poor's downgraded the company's senior notes to "BB-" from "BB" in April 2026, which could impact borrowing costs.
Investor Verification Checklist
- Membership Attrition: Verify the sustainability of the 14% membership decline and the specific impact of the Virginia contract expiration and Marketplace strategy on future revenue.
- MCR Trajectory: Monitor the Medical Care Ratio closely; the increase to 92.2% indicates rising medical costs that are outpacing premium revenue growth.
- MAPD Exit Execution: Assess the financial impact of the $93 million impairment and the operational success of transitioning to a dual-eligible focused Medicare strategy.
- Legislative Impact: Evaluate the potential long-term revenue reduction from the OBBBA work requirements and provider tax limitations starting in 2027-2028.
- Litigation Exposure: Track the outcome of the securities class action lawsuit and any potential financial liabilities.
- Credit Covenants: Confirm continued compliance with the amended Interest Coverage Ratio covenants under the Credit Agreement, which were temporarily reduced to 1.75:1.00 for the current period.